p. 8133 - 8135
(2004)p. 3101 - 3104
(2007/10/03)p. 4127 - 4130
(2008/09/19)p. 5671 - 5673
(2007/10/02)p. 6689 - 6704
(2007/10/02)p. 362 - 365
(2007/10/02)p. 1137 - 1139
(2007/10/02)p. 6353 - 6356
(2007/10/02)p. 1067 - 1070
(2007/10/02)p. 579 - 582
(2007/10/02)p. 5087 - 5090
(2007/10/02)p. 2866 - 2869
(2007/10/02)p. 3497 - 3500
(2007/10/02)p. 3493 - 3496
(2007/10/02)5-[(3aS,5R,6R,6aS)-5-Hydroxy-6-((E)-(S)-3-hydroxy-oct-1-enyl)-1,3a,4,5,6,6a-hexahydro-pentalen-2-yl]-1-trimethylsilanyl-pentan-1-one
5-[(3aS,5R,6S,6aS)-5-(Tetrahydro-pyran-2-yloxy)-6-(tetrahydro-pyran-2-yloxymethyl)-1,3a,4,5,6,6a-hexahydro-pentalen-2-yl]-pentanal
5-[(3aR,5S,6S,6aR)-5-Hydroxy-6-((E)-(R)-3-hydroxy-oct-1-enyl)-1,3a,4,5,6,6a-hexahydro-pentalen-2-yl]-pentanoic acid methyl ester
5-{(3aR,5S,6S,6aR)-5-(tert-Butyl-dimethyl-silanyloxy)-6-[(E)-(R)-3-(tert-butyl-dimethyl-silanyloxy)-oct-1-enyl]-1,3a,4,5,6,6a-hexahydro-pentalen-2-yl}-pentanoic acid
isocarbacyclin